CXCL5 and neoplasm: Mechanistically, YAP upregulates the expression of C-X-C motif chemokine 5 (CXCL5) in tumor cells to recruit myeloid-derived suppressor cells, and appropriately, the use of antibodies to target CXCL5 suppresses tumor progression [176].